costeff syndrome aciduria type iii genetic disorder caused mutations typically associated onset visual deterioration optic atrophy early childhood followed development movement problems motor disability later childhood occasionally along mild cases cognitive disorder named hanan costeff doctor first described syndrome characteristic symptom costeff syndrome onset progressively worsening eyesight caused degeneration optic nerve optic atrophy within first years childhood majority affected individuals also developing motor disabilities later occasionally people costeff syndrome may also experience mild cognitive type aciduria hallmark increased level urinary concentrations acid acid allow diagnosis early one year costeff syndrome typically experience first symptoms visual deterioration within first years childhood manifests onset progressively decreasing visual acuity decrease tends continue age even majority people costeff syndrome develop movement problems motor disabilities later childhood two significant choreoathetosis former causes involuntary erratic jerky twisting movements see chorea athetosis whereas latter causes twitches spastic tendencies two symptoms often severe enough seriously disable individual among people costeff syndrome experienced major motor disability result choreoathetosis experienced spasticityrelated symptoms severe enough ataxia loss muscle coordination speech impairment caused dysarthria also occur roughly cases rarely seriously individuals costeff disease also display mild cognitive impairment though cases relatively costeff syndrome neuroophthalmological genetic disorder specifically autosomal recessive disorder caused mutation gene carries instructions synthesis gene product protein exact function product protein unknown though known play integral role mitochondrial disorder caused several different mutations gene however nearly reported cases costeff syndrome individuals iraqi jewish origin share splice site founder particular founder mutation gtoc mutation single nucleotide see singlenucleotide polymorphism interferes gene expression levels though mutation within population severity symptoms varies date two reported cases costeff syndrome due founder mutation due different pathogenic variants two mutations also reported result rare dominant genetic disorder symptoms similar costeff costeff syndrome diagnosed presence increased levels acid urine currently cure costeff syndrome treatment supportive thus focuses management symptoms resulting visual impairment spasticity movement disorders treated way similar cases occurring general longterm prognosis costeff syndrome unknown though appears effect life expectancy least fourth decade however mentioned previously movement problems often severe enough confine individuals wheelchair early age visual acuity spasticity tend worsen time first described costeff syndrome reported almost exclusively individuals iraqi jewish origin two exceptions one turkish kurdish indian within iraqi jewish population carrier frequency founder mutation prevalence costeff syndrome estimated anywhere httpsenwikipediaorgwikicosteffsyndrome